Table 2.

Predictors of Prevalent Atrial Fibrillation

	2005 Crude		2005 Fully-adjusted		All Years Fully-adjusted
	Odds Ratio	95% CI	Odds Ratio	95% CI	Odds Ratio	95% CI
Age (per year)	1.04	1.02 – 1.05	1.02	1.01 – 1.04	1.02	1.01 – 1.03
Female (vs. Male)	0.85	0.69 – 1.03	0.83	0.67 – 1.02	0.92	0.81 – 1.05
Race (vs. Caucasian)
African American	0.53	0.42 – 0.66	0.52	0.41 – 0.67	0.60	0.55 – 0.65
Asian American	0.37	0.15 – 0.89	0.44	0.18 – 1.09	0.58	0.50 – 0.67
Medicaid (vs. no Medicaid beneficiary)	0.93	0.75 – 1.15	0.95	0.75 – 1.21	0.91	0.80 – 1.04
Years since first ESRD treatment (per year)	1.03	1.01 – 1.06	1.04	1.01 – 1.07	1.03	1.01 – 1.05
Underlying kidney disease (vs. DN)
Hypertensive nephropathy	1.33	1.07 – 1.65	1.32	1.03 – 1.71	1.28	1.09 – 1.50
Glomerulonephritis	1.58	1.09 – 2.29	1.50	0.99 – 2.28	1.29	1.00 – 1.66
Other kidney disease	1.12	0.82 – 1.52	1.09	0.76 – 1.55	1.28	1.03 – 1.59
Comorbidities (vs. absence of comorbidity)
Diabetes	1.02	0.80 – 1.31	1.11	0.83 – 1.48	1.13	0.97 – 1.32
Hypertension	5.42	0.71 – 41.3	2.87	0.36 – 22.8	1.48	0.97 – 2.25
Heart failure	4.64	3.06 – 7.03	3.40	2.20 – 5.25	3.40	2.70 – 4.27
Coronary artery disease	2.11	1.68 – 2.64	1.54	1.21 – 1.97	1.61	1.41 – 1.85
Cerebrovasular disease	1.58	1.30 – 1.92	1.38	1.12 – 1.70	1.20	1.06 – 1.35
Peripheral artery disease	1.66	1.34 – 2.05	1.15	0.91 – 1.46	1.30	1.15 – 1.48
Chronic obstructive pulmonary disease	1.85	1.52 – 2.25	1.45	1.18 – 1.79	1.42	1.26 – 1.60
Cancer (excl. non-melanoma skin cancer)	1.16	0.91 – 1.49	1.11	0.84 – 1.45	1.21	1.02 – 1.44
Unable to ambulate	1.46	0.85 – 2.50	1.20	0.64 – 2.25	1.58	1.10 – 2.27
Unable to transfer	1.30	0.44 – 3.83	1.13	0.32 – 3.92	0.98	0.52 – 1.87
Calendar year	N.A.		N.A.		1.03	1.00 – 1.05

Note: CI – confidence interval; DN – diabetic nephropathy; ESRD – end-stage renal disease